GSA Capital Partners LLP Cuts Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

GSA Capital Partners LLP lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 84.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,880 shares of the medical instruments supplier’s stock after selling 52,930 shares during the quarter. GSA Capital Partners LLP’s holdings in DENTSPLY SIRONA were worth $267,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Raymond James Trust N.A. lifted its position in DENTSPLY SIRONA by 4.9% in the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after buying an additional 453 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares during the last quarter. LRI Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares in the last quarter. Diversified Trust Co grew its holdings in shares of DENTSPLY SIRONA by 3.0% during the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after purchasing an additional 566 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in shares of DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI dropped their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Barrington Research decreased their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Finally, Needham & Company LLC decreased their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Trading Up 0.7 %

Shares of XRAY stock opened at $18.77 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60. The stock has a market capitalization of $3.73 billion, a P/E ratio of -9.07, a P/E/G ratio of 1.83 and a beta of 1.02. The firm’s 50 day moving average is $23.25 and its 200 day moving average is $25.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the prior year, the company earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% on a year-over-year basis. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.